-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Author Archive: Jason Corum
Jason is the web editor with the Biotechnology Industry Organization (BIO). Prior to joining BIO in March 2011, he was the online communications manager for World Food Program USA and an online communications specialist with the Brookings Institution.
Jason is originally from Evergreen Park, Ill. and still thinks that Chicago is the best food city in the nation. He spends his free time volunteering with the DC Books to Prisons Project, watching movies and following Ozzie Guillen on Twitter.Latest Posts
BIO Official Blogger Roundup
Want to know what’s happening at the 2012 BIO International Convention? Find out from our BIO Official Bloggers! Denmark leads the world in its pro-research attitude #bio2012, Biotech Blog Bioentrepreneurship Bootcamp signing at #bio2012, Biotech Blog Welcome to BIO 2012!, Campaign for Modern Medicine Greetings from BIO 2012!, The Cross-Border Biotech Blog BIORadio Lands in Boston, Genomics Blog Kicking off #BIO2012, LillyPad Research Partnerships Catalyze Economic Growth, LillyPad The BIO Official Bloggers Take Boston, Patent Baristas BIO Day 1: China, IP and Savings Read More >
Five Keys to Making Biotech Flourish in China
As China positions itself as a major global player in the international biotechnology arena, it has included biotechnology as one of the seven strategic priorities for scientific and technological development in its 12th Five-year Plan. During the keynote lunch of the China Day special program at the 2012 BIO International Convention, David W. Beier, senior vice president at Amgen and former chief domestic policy advisor to Vice President Al Gore, outlined the 5 keys to Read More >
BIO Official Bloggers Preview the Convention
Want to know what to expect at the 2012 BIO International Convention? Find out from our BIO Official Bloggers: “… most importantly for this blog, the Boston area is home to, arguably, the United State’s most vibrant biotech scene. Data from Ernst & Young’s Beyond Borders report from 2011 show that New England biotech (consisting primarily of the Boston area) had 45 public companies in 2010, second only to the San Francisco Bay Area, with Read More >
Your Social Media Guide to #BIO2012
The BIO International Convention is the largest global event for the biotechnology industry; it attracts the biggest names in biotech and offers key networking and partnering opportunities. The event is also a great opportunity to connect with the online biotech community and we’re ramping up our social media efforts for the 2012 BIO International Convention, beginning on Monday, June 18 in Boston. If you’d like to join the online conversation, here are some tips, tricks, Read More >
Picks and Pans – The Buy-Side View for 2012
What’s the forecast for biotech in 2012? Do investors think it is a good time to invest in biotechnology? Are they interested in taking on early stage companies? At the BIO CEO & Investor Conference opening plenary, the BIO Industry Analysis team released results from their Investor Perception Study and, afterwards, a panel of portfolio managers and senior buy-side analysts fielded a range of question about the challenges and opportunities facing the industry. David Gluckman, M.D., Read More >
